[Oxyferriscorbone: anti-ulcer effect and its possible mechanisms].
Rasulov
M M
MM
Kuznetsov
I G
IG
Zabozlaev
A G
AG
Voronkov
M G
MG
D015083:2,3-Diketogulonic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D000496:Alloxan / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004338:Drug Combinations; D005290:Ferric Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D005456:Fluorescent Dyes; D015227:Lipid Peroxidation / Q000187:drug effects; D008163:Luminescent Measurements; D008564:Membrane Potentials / Q000187:drug effects; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D005290:Ferric Compounds; D005456:Fluorescent Dyes; D015083:2,3-Diketogulonic Acid; C008747:oxyferriscorbone; D000496:Alloxan